大脑缩的性别差异 在患有莱维体的痴呆症中
Javier Oltra1,2,3, Annegret Habich3,4, Christopher G Schwarz5
1Medical Psychology Unit, Department of Medicine, Institute of Neuroscience, University of Barcelona, Barcelona, Catalonia, Spain.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 22, 2023
概括
患有莱维体 (DLB) 痴呆症的男性表现出更大的前脑缩,而女性则具有更薄的嗅觉皮层. 大脑缩中的这些性别差异随着年龄的增长而减少,接近75岁左右.
科学领域:
- 神经科学是一个神经科学.
- 神经学 神经学
- 放射学 放射学是一门学科.
背景情况:
- 性影响神经退行,但对痴呆症与勒维体 (DLB) 大脑缩中的性别差异的研究有限.
- 了解这些差异对于诊断和治疗DLB至关重要.
研究的目的:
- 用磁共振成像 (MRI) 来研究DLB患者脑缩模式的性别差异.
- 探索年龄对大脑结构中这些与性别相关的差异的影响.
主要方法:
- 利用了来自欧洲DLB联盟和梅奥诊所的436名DLB患者的数据.
- 通过视力缩评分尺度和区域灰质体积和皮质厚度的自动估计,评估性别差异和性别年龄相互作用.
主要成果:
- 男性在六个皮层区域表现出更高的额头缩和灰质体积减少的可能性.
- 女性的嗅觉皮层较薄.
- 在灰色物质体积和皮质皮层的皮层厚度上都观察到显著的性别年龄相互作用.
结论:
- 患有DLB的男性在年轻时出现更广泛的皮质缩,特别是在额头区域.
- 大脑结构中的这些基于性别的差异倾向于随着年龄的增长而减少,男性和女性的模式在75岁左右趋同.
更多相关视频
08:29Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans
Published on: December 18, 2016
14.1K
07:03Evaluation of Hemisphere Lateralization with Bilateral Local Field Potential Recording in Secondary Motor Cortex of Mice
Published on: July 31, 2019
6.8K
相关概念视频
Neural Regulation
39.5K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.5K
Dementia
115
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
115
Alzheimer's Disease: Overview
492
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
492
